🇺🇸 FDA
Pipeline program

Botulinum Toxin Type B (Myobloc)

SN-SIAL-201

Phase 2 mab completed

Quick answer

Botulinum Toxin Type B (Myobloc) for Drooling is a Phase 2 program (mab) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Drooling
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials